Besides RBMY, HBx-activated AKT and ERKs also phosphorylate and inactivate GSK3β, leading to stabilization of β-catenin and CyclinD1 gene transcription, and promoting the development of HCC [38]. The gene discussed is RBMY1A1; the disease is hepatocellular carcinoma.